{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:32:53Z","timestamp":1760851973966,"version":"3.30.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[1999,1,29]],"date-time":"1999-01-29T00:00:00Z","timestamp":917568000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[1999,2]]},"DOI":"10.1038\/sj.bjc.6690143","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T14:02:07Z","timestamp":1032271327000},"page":"895-902","source":"Crossref","is-referenced-by-count":44,"title":["p21WAF1\/CIP1 expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival"],"prefix":"10.1038","volume":"79","author":[{"given":"J M","family":"Karjalainen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M J","family":"Eskelinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J K","family":"Kellokoski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Reinikainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E M","family":"Alhava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V-M","family":"Kosma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1999,1,29]]},"reference":[{"key":"BF6690143_CR1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/BF01212727","volume":"119","author":"S Aaltomaa","year":"1993","unstructured":"Aaltomaa, S., Lipponen, P., Papinaho, S. & Syrj\u00e4nen, K. (1993). Proliferating-cell nuclear antigen (PC10) immunolabelling and other proliferation indices as prognostic factors in breast cancer. J Cancer Res Clin Oncol, 119, 288\u2013294.","journal-title":"J Cancer Res Clin Oncol"},{"key":"BF6690143_CR2","doi-asserted-by":"crossref","first-page":"8405","DOI":"10.1073\/pnas.88.19.8405","volume":"88","author":"AL Borresen","year":"1991","unstructured":"Borresen, A. L., Hovig, E., Smith Sorensen, B., Malkin, D., Lystad, S., Andersen, T. I., Nesland, J. M., Isselbacher, K. J. & Friend, S. H. (1991). Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations. Proc Natl Acad Sci USA, 88, 8405\u20138409.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6690143_CR3","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1097\/00000658-197011000-00017","volume":"12","author":"A Breslow","year":"1970","unstructured":"Breslow, A. (1970). Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg, 12, 902\u2013908.","journal-title":"Ann Surg"},{"key":"BF6690143_CR4","first-page":"1931","volume":"11","author":"I-T Chen","year":"1995","unstructured":"Chen, I-T, Smith, M. L., O\u2019Connor, P. M. & Fornace, A. J. (1995). Direct interaction of Gadd45 with PCNA and evidence for competitive interaction of Gadd45 with p21Wafl\/Cip1 with PCNA. Oncogene, 11, 1931\u20131937.","journal-title":"Oncogene"},{"key":"BF6690143_CR5","first-page":"705","volume":"29","author":"WH Clark Jr","year":"1969","unstructured":"Clark Jr, W. H., From, L., Bernardino, E. A. & Mihm, M. C. (1969). The histogenesis and biologic behaviour of primary human malignant melanomas of the skin. Cancer Res, 29, 705\u2013726.","journal-title":"Cancer Res"},{"key":"BF6690143_CR6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox, D. R. (1972). Regression models and life tables with discussion. J Stat Soc B, 34, 187\u2013192.","journal-title":"J Stat Soc B"},{"key":"BF6690143_CR7","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1128\/JVI.66.10.6164-6170.1992","volume":"66","author":"S Deb","year":"1992","unstructured":"Deb, S., Jackson, C. T., Subler, M. A. & Martin, D. W. (1992). Modulation of cellular and viral promoters by mutant human p53 proteins found in tumour cells. J Virol, 66, 6164\u20136170.","journal-title":"J Virol"},{"key":"BF6690143_CR8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1023\/A:1005752829260","volume":"43","author":"SG Diab","year":"1997","unstructured":"Diab, S. G., Yu, Y. Y., Hilsenbeck, S. G., Allred, D. C. & Elledge, R. M. (1997). WAF1\/CIP1 protein expression in human breast tumors. Breast Cancer Res Treat, 43, 99\u2013103.","journal-title":"Breast Cancer Res Treat"},{"key":"BF6690143_CR9","first-page":"884","volume":"147","author":"JA DiGiuseppe","year":"1995","unstructured":"DiGiuseppe, J. A., Redston, M. S., Yeo, C. J., Kern, S. E. & Hruban, R. H. (1995). p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma. Am J Pathol, 147, 884\u2013888.","journal-title":"Am J Pathol"},{"key":"BF6690143_CR10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/(SICI)1096-9896(199607)179:3<248::AID-PATH571>3.0.CO;2-6","volume":"179","author":"C Doglioni","year":"1996","unstructured":"Doglioni, C., Pelosio, P., Laurino, L., Macri, E., Meggiolaro, E., Favretti, F. & Barbareschi, M. (1996). p21\/WAF1\/CIP1 expression in normal mucosa and in adenomas and adenocarcinomas of the colon: its relationship with differentiation. J Pathol, 179, 248\u2013253.","journal-title":"J Pathol"},{"key":"BF6690143_CR11","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","volume":"75","author":"WS El-Deiry","year":"1993","unstructured":"El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W. & Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumour suppression. Cell, 75, 817\u2013825.","journal-title":"Cell"},{"key":"BF6690143_CR12","first-page":"2910","volume":"55","author":"WS El-Deiry","year":"1995","unstructured":"El-Deiry, W. S., Tokino, T., Waldman, T., Oliner, J. D., Velculescu, V. E., Burrell, M., Hill, D. E., Healy, E., Rees, J. L., Hamilton, S. R., Kinzler, K. W. & Vogelstein, B. (1995). Topological control of p21WAF1\/cip1 expression in normal and neoplastic tissues. Cancer Res, 55, 2910\u20132919.","journal-title":"Cancer Res"},{"key":"BF6690143_CR13","doi-asserted-by":"crossref","first-page":"8655","DOI":"10.1073\/pnas.91.18.8655","volume":"91","author":"H Flores-Rozas","year":"1994","unstructured":"Flores-Rozas, H., Kelman, Z., Dean, F. B., Pan, Z. Q., Harper, J. W., Elledge, S. J., O\u2019Donnell, M. O. & Hurwitz, J. (1994). Cdk-interacting protein I directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme. Proc Natl Acad Sci USA, 91, 8655\u20138659.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6690143_CR14","first-page":"530","volume":"8","author":"L Gelsleichter","year":"1995","unstructured":"Gelsleichter, L., Gown, A. M., Zarbo, R. J., Wang, E. & Coltera, M. D. (1995). P53 and mdm-2 expression in malignant melanoma: an immunohistochemical study of expression of p53, mdm-2, and markers of cell proliferation in primary versus metastatic tumours. Modern Pathol, 8, 530\u2013535.","journal-title":"Modern Pathol"},{"key":"BF6690143_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.1711720103","volume":"172","author":"PA Hall","year":"1994","unstructured":"Hall, P. A. & Lane, D. P. (1994). p53 in tumour pathology: can we trust immunohistochemistry? \u2013 Revisited!. J Pathol, 172, 1\u20134.","journal-title":"J Pathol"},{"key":"BF6690143_CR16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.1997.382","volume":"76","author":"N Harada","year":"1997","unstructured":"Harada, N., Gansauge, S., Gansauge, F., Gause, H., Shimoyama, S., Imaizumi, T., Mattfeld, T., Schoenberg, M. H. & Beger, H. G. (1997). Nuclear accumulation of p53 correlates significantly with clinical features and inversely with the expression of the cyclin-dependent kinase inhibitor p21WAF1\/CIP1 in pancreatic cancer. Br J Cancer, 76, 299\u2013305.","journal-title":"Br J Cancer"},{"key":"BF6690143_CR17","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0092-8674(93)90499-G","volume":"75","author":"JW Harper","year":"1993","unstructured":"Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K. & Elledge, S. J. (1993). The p21-Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75, 805\u2013816.","journal-title":"Cell"},{"key":"BF6690143_CR18","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1038\/sj.onc.1201080","volume":"14","author":"H Hiyama","year":"1997","unstructured":"Hiyama, H., Iavarone, A., LaBaer, J. & Reeves, S. A. (1997). Regulated ectopic expression of cyclin D1 induces transcriptional activation of the cdk inhibitor p21 gene without altering cell cycle progression. Oncogene, 14, 2533\u20132542.","journal-title":"Oncogene"},{"key":"BF6690143_CR19","first-page":"1855","volume":"10","author":"H Jiang","year":"1995","unstructured":"Jiang, H., Lin, J., Su, Z. Z., Herlyn, M., Kerbel, R. S., Weissman, B. E., Welch, D. R. & Fisher, P. B. (1995). The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. Oncogene, 10, 1855\u20131864.","journal-title":"Oncogene"},{"key":"BF6690143_CR20","first-page":"2021","volume":"11","author":"JM Jung","year":"1995","unstructured":"Jung, J. M., Bruner, J. M., Ruan, S., Langford, L. A., Kyritsis, A. P., Kobayashi, T., Levin, V. A. & Zhang, W. (1995). Increased levels of p21WAF1\/Cip1 in human brain tumors. Oncogene, 11, 2021\u20132028.","journal-title":"Oncogene"},{"key":"BF6690143_CR21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan, E. L. & Meier, P. (1958). Nonparametric estimation from incomplete observations. J Am Stat Assoc, 53, 457\u2013481.","journal-title":"J Am Stat Assoc"},{"key":"BF6690143_CR22","first-page":"2235","volume":"53","author":"NJ Lassam","year":"1993","unstructured":"Lassam, N. J., From, L. & Kahn, H. J. (1993). Overexpression of p53 is a late event in the development of malignant melanoma. Cancer Res, 53, 2235\u20132238.","journal-title":"Cancer Res"},{"key":"BF6690143_CR23","first-page":"1813","volume":"149","author":"GM Maelandsmo","year":"1996","unstructured":"Maelandsmo, G. M., Holm, R., Fodstad, \u00d8, Kerbel, R. S. & Florenes, V. A. (1996). Cyclin kinase inhibitor p21WAF1\/CIP1 in malignant melanoma. Am J Pathol, 149, 1813\u20131822.","journal-title":"Am J Pathol"},{"key":"BF6690143_CR24","first-page":"1170","volume":"146","author":"MF Melhem","year":"1995","unstructured":"Melhem, M. F., Law, J. C., El-Ashmawy, L., Johnson, J. T., Landreneau, R. J., Srivastava, S. & Whiteside, T. L. (1995). Assessment of sensivity and specifity of immunohistochemical staining of p53 in lung and head and neck cancers. Am J Pathol, 146, 1170\u20131177.","journal-title":"Am J Pathol"},{"key":"BF6690143_CR25","first-page":"3391","volume":"54","author":"P Michieli","year":"1994","unstructured":"Michieli, P., Chedid, M., Lin, D., Pierce, J. H., Mercer, W. E. & Givol, D. (1994). Induction of WAF1\/CIP1 by a p53-independent pathway. Cancer Res, 54, 3391\u20133395.","journal-title":"Cancer Res"},{"key":"BF6690143_CR26","doi-asserted-by":"crossref","first-page":"7262","DOI":"10.1073\/pnas.89.15.7262","volume":"89","author":"UM Moll","year":"1992","unstructured":"Moll, U. M., Riou, G. & Levine, A. J. (1992). Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci USA, 89, 7262\u20137266.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6690143_CR27","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/(SICI)1096-9896(199710)183:2<156::AID-PATH908>3.0.CO;2-O","volume":"183","author":"A Nadal","year":"1997","unstructured":"Nadal, A., Jares, P., Cazorla, M., Fernandez, P. L., Sanjuan, X., Hernandez, L., Pinyol, M., Aldea, M., Mallofre, C., Muntane, J., Traserra, J., Campo, E. & Cardesa, A. (1997). p21WAF1\/Cip1 expression is associated with cell differentiation but not with p53 mutations in squamous cell carcinomas of the larynx. J Pathol, 183, 156\u2013163.","journal-title":"J Pathol"},{"key":"BF6690143_CR28","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0046-8177(97)90077-0","volume":"28","author":"KN Naresh","year":"1997","unstructured":"Naresh, K. N., O\u2019Conor, G. T., Soman, C. S., Johnson, J., Advani, S. H., Magrath, I. T. & Bhatia, K. G. (1997). A study of p53 protein, proliferating cell nuclear antigen, and p21 in Hodgkin\u2019s disease at presentation and relapse. Hum Pathol, 28, 549\u2013555.","journal-title":"Hum Pathol"},{"key":"BF6690143_CR29","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1200\/JCO.1996.14.2.497","volume":"14","author":"M Nishio","year":"1996","unstructured":"Nishio, M., Koshikawa, T., Kuroishi, T., Suyama, M., Uchida, K., Takagi, Y., Washimi, O., Sugiura, T., Ariyoshi, Y., Takahashi, T., Ueda, R. & Takahashi, T. (1996). Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers. J Clin Oncol, 14, 497\u2013502.","journal-title":"J Clin Oncol"},{"key":"BF6690143_CR30","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1002\/j.1460-2075.1994.tb06656.x","volume":"13","author":"K Ory","year":"1994","unstructured":"Ory, K., Legros, Y., Auguin, C. & Soussi, T. (1994). Analysis of the most representative tumour-derived p53 mutants reveals that changes in protein conformation are not correlated with loss of transactivation or inhibition of cell proliferation. EMBO J, 13, 3496\u20133504.","journal-title":"EMBO J"},{"key":"BF6690143_CR31","doi-asserted-by":"crossref","first-page":"8869","DOI":"10.1021\/bi00027a039","volume":"34","author":"VN Podust","year":"1995","unstructured":"Podust, V. N., Podust, L. M., Goubin, F., Ducommun, B. & Hubscher, U. (1995). Mechanism of inhibition of proliferating cell nuclear antigen-dependent DNA synthesis by the cyclin-dependent kinase inhibitor p21. Biochemistry, 34, 8869\u20138875.","journal-title":"Biochemistry"},{"key":"BF6690143_CR32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2133.1993.tb00164.x","volume":"128","author":"YS Ro","year":"1993","unstructured":"Ro, Y. S., Cooper, P. N., Lee, J. A., Quinn, A. G., Harrison, D., Lane, D., Horne, C. H., Rees, J. L. & Angus, B. (1993). p53 protein expression in benign and malignant skin tumours. Br J Dermatol, 128, 237\u2013241.","journal-title":"Br J Dermatol"},{"key":"BF6690143_CR33","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00008390-199512000-00001","volume":"5","author":"LE Sparrow","year":"1995","unstructured":"Sparrow, L. E., English, D. R., Heenan, P. J., Dawkins, H. J. & Taran, J. (1995). Prognostic significance of p53 over-expression in thin melanomas. Melanoma Res, 5, 387\u2013392.","journal-title":"Melanoma Res"},{"key":"BF6690143_CR34","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0344-0338(96)80056-2","volume":"192","author":"L Talve","year":"1996","unstructured":"Talve, L., Kainu, J., Collan, Y. & Ekfors, T. (1996). Immunohistochemical expression of p53 protein, mitotic index and nuclear morphometry in primary malignant melanoma of the skin. Pathol Res Pract, 192, 825\u2013833.","journal-title":"Pathol Res Pract"},{"key":"BF6690143_CR35","first-page":"1139","volume":"149","author":"VA Tron","year":"1996","unstructured":"Tron, V. A., Tang, L., Yong, W. P. & Trotter, M. J. (1996). Differentiation-associated overexpression of the cyclin-dependent kinase inhibitor p21waf-1 in human cutaneous squamous cell carcinoma. Am J Pathol, 149, 1139\u20131146.","journal-title":"Am J Pathol"},{"key":"BF6690143_CR36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-0560.1997.tb00790.x","volume":"24","author":"MJ Trotter","year":"1997","unstructured":"Trotter, M. J., Tang, L. & Tron, V. A. (1997). Overexpression of the cyclin-dependent kinase inhibitor p21waf-1\/CIP1 in human cutaneous malignant melanoma. J Cutan Pathol, 24, 265\u2013271.","journal-title":"J Cutan Pathol"},{"key":"BF6690143_CR37","unstructured":"UICC (1987). TNM Classification of Malignant Tumours, 4th edn., Springer-Verlag, Berlin; pp. 88\u201390."},{"key":"BF6690143_CR38","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00008390-199508000-00006","volume":"5","author":"MJ Vidal","year":"1995","unstructured":"Vidal, M. J., Loganzo, F., de Oliveira, A. R., Hayward, N. K. & Albino, A. P. (1995). Mutations and defective expression of the WAF1 p21 tumour-suppressor gene in malignant melanomas. Melanoma Res, 5, 243\u2013250.","journal-title":"Melanoma Res"},{"key":"BF6690143_CR39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.1365-2559.1996.d01-558.x","volume":"30","author":"T Vogt","year":"1997","unstructured":"Vogt, T., Zipperer, K. H., Vogt, A., Holzel, D., Landthaler, M. & Stolz, W. (1997). p53-protein and Ki-67-antigen expression are both reliable biomarkers of prognosis in thick stage I nodular melanomas of the skin. Histopathology, 30, 57\u201363.","journal-title":"Histopathology"},{"key":"BF6690143_CR40","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0022-1759(92)90122-A","volume":"51","author":"B Vojtesek","year":"1992","unstructured":"Vojtesek, B., Bontek, J., Midgley, C. A. & Lane, D. P. (1992). An immunochemical analysis of human p53: new monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods, 51, 237\u2013244.","journal-title":"J Immunol Methods"},{"key":"BF6690143_CR41","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/369574a0","volume":"369","author":"S Waga","year":"1994","unstructured":"Waga, S., Hannon, G. J., Beach, D. & Stillman, B. (1994). The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature, 369, 574\u2013578.","journal-title":"Nature"},{"key":"BF6690143_CR42","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/ajcp\/107.6.684","volume":"107","author":"E Wakasugi","year":"1997","unstructured":"Wakasugi, E., Kobayashi, T., Tamaki, Y., Ito, Y., Miyashiro, I., Komoike, Y., Takeda, T., Shin, E., Takatsuka, Y., Kikkawa, N., Monden, T. & Monden, M. (1997). p21(Waf1\/Cip1) and p53 protein expression in breast cancer. Am J Clin Pathol, 107, 684\u2013691.","journal-title":"Am J Clin Pathol"},{"key":"BF6690143_CR43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2133.1995.tb02487.x","volume":"133","author":"J Weiss","year":"1995","unstructured":"Weiss, J., Heine, M., K\u00f6rner, B., Pilch, H. & Jung, E. G. (1995). Expression of p53 protein in malignant melanoma: clinicopathological and prognostic implications. Br J Dermatol, 133, 23\u201331.","journal-title":"Br J Dermatol"},{"key":"BF6690143_CR44","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/path.1711660402","volume":"166","author":"D Wynford-Thomas","year":"1992","unstructured":"Wynford-Thomas, D. (1992). P53 in tumour pathology: can we trust immunohistochemistry?. J Pathol, 166, 329\u2013330.","journal-title":"J Pathol"},{"key":"BF6690143_CR45","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/BF01262323","volume":"287","author":"M Yamamoto","year":"1995","unstructured":"Yamamoto, M., Takahashi, H., Saitoh, K., Horikoshi, T. & Takahashi, M. (1995). Expression of the p53 protein in malignant melanomas as a prognostic indicator. Arch Dermatol Res, 287, 146\u2013151.","journal-title":"Arch Dermatol Res"},{"key":"BF6690143_CR46","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/(SICI)1096-9896(199610)180:2<122::AID-PATH647>3.0.CO;2-C","volume":"180","author":"W Yasui","year":"1996","unstructured":"Yasui, W., Akama, Y., Kuniyasu, H., Yokozaki, H., Semba, S., Shimamoto, F. & Tahara, E. (1996). Expression of cyclin-dependent kinase inhibitor p21WAF1\/CIP1 in non-neoplastic mucosa and neoplasia of the stomach: relationship with p53 status and proliferative activity. J Pathol, 180, 122\u2013128.","journal-title":"J Pathol"},{"key":"BF6690143_CR47","first-page":"1557","volume":"12","author":"Y-X Zeng","year":"1996","unstructured":"Zeng, Y-X & El-Deiry, W. S. (1996). Regulation of p21WAF1\/CIP1 expression by p53-independent pathways. Oncogene, 12, 1557\u20131564.","journal-title":"Oncogene"},{"key":"BF6690143_CR48","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/ng0197-78","volume":"15","author":"Y-X Zeng","year":"1997","unstructured":"Zeng, Y-X, Somasundaram, K. & El-Deiry, W. S. (1997). AP2 inhibits cancer cell growth and activates p21WAF1\/CIP1 expression. Nature Genet, 15, 78\u201382.","journal-title":"Nature Genet"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6690143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690143","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:29Z","timestamp":1733788829000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6690143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1,29]]},"references-count":48,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[1999,2]]}},"alternative-id":["BF6690143"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6690143","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"type":"print","value":"0007-0920"},{"type":"electronic","value":"1532-1827"}],"subject":[],"published":{"date-parts":[[1999,1,29]]}}}